shop by

Kinase Inhibitor Drugs (Hardcover)

Customer Reviews   Write a Review

Be the first to review this item and earn 25 Rakuten Super Points™

Product Overview

A comprehensive resource on case studies of marketed kinase drugs and promising drug trials

Since the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the treatment of chronic myelogenous leukemia and seven additional marketed kinase inhibitor drugs, researchers have compelling evidence that kinase inhibitors can be highly efficacious in the treatment of diseases caused by aberrant activity of protein kinase. Currently more than 100 protein kinase inhibitors are in clinical development.

In one comprehensive volume, the editors, Dr. Rongshi Li and Dr. Jeffrey Stafford, present timely and important case studies of marketed kinase drugs and several of the most advanced kinase inhibitors in clinical trials. Kinase Inhibitor Drugs includes:

  • Case studies from leading investigators and experts in the field that provide firsthand accounts of kinase inhibitor discovery

  • Current thinking on kinase structure, biochemistry, and signal transduction pathways

  • Information on state-of-the-art technologies and tools such as structure-based and fragment-based drug discovery

  • A lineup of clinical-phase growth factor receptor inhibitors

  • Inhibitors of cell cycle kinases

  • The discovery of allosteric inhibitors of MEK kinase

  • Information on pharmacogenomics and its application to kinase inhibitor clinical development


Publisher John Wiley & Sons Inc
Mfg Part# 9780470278291
SKU 211285956
Format Hardcover
ISBN10 0470278293
Release Date 11/1/2009
Product Attributes
Book Format Hardcover
Number of Pages 0510
Publisher John Wiley & Sons
Series Part 10
Sold Out
Sorry, you missed the deal!
This product is currently not available.
Promotions & Offers (1)
  •  custom promo
    5% Back* Sitewide with Promo Code Rewardme *See page for details